| Ytd | -31.01% | |
| 1y | 14.38% |
| Open | 3.94 | Prev Close | 3.93 | Low | 3.86 | High | 3.98 | Mkt Cap | 1.25B |
| Vol | 1.74M | Avg Vol | 5.22M | EPS | -0.13 | P/E | -30.08 | Forward P/E | 33.33 |
| Beta | 1.12 | Short Ratio | 5.19 | Inst. Own | 58.18% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.92 | 200-d Avg | 4.29 | 1yr Est | 7.97 |
MannKind Corporation (MNKD) Q2 2026 Earnings Call Transcript
MannKind NASDAQ: MNKD reported second-quarter revenue of $109.4 million, up 43% from the prior-year
The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter
MannKind (MNKD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimat
Achieved three major catalysts to drive future growth: Launched the pediatric indication of Afrezza
MannKind Corporation (MNKD) Discusses Phase 1b Results and Clinical Progress of Nintedanib DPI for I
MannKind NASDAQ: MNKD reported Phase 1b results for its inhaled nintedanib dry-powder inhalation, or
We also report on an experimental diagnostic approach that can detect tuberculosis exposure and inf
MNKD Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety & Tolerability of Nintedanib DP
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation
MannKind Corporation (NASDAQ: MNKD - Get Free Report)'s stock price gapped up prior to trading on Fr
Mannkind Corporation (NASDAQ:MNKD) shares are trading higher as the company recently announced the U
MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic
MannKind NASDAQ: MNKD said the U.S. Food and Drug Administration approved Furoscix ReadyFlow, an aut
DANBURY, Conn. and WESTLAKE VILLAGE, Calif.
MannKind announces FDA approval of Furoscix ReadyFlow™, the first & only autoinjector delivering IV-
This MannKind insider filing details the disposition of 46,795 shares. The transaction reduced the i
The transactions involved 76,880 shares with a total value of about $313,000, based on a weighted av
David Thomson disposed of 123,000 shares at $4.08 per share, representing a total transaction value
This filing reported an insider's total disposition of 65,808 shares for an estimated value of $269,
U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ:
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to repor
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90.
Gainers Cyren Ltd. (NASDAQ: CYRN) shares surged 118.9% to settle at $4.75 on Thursday. Cyren rece
Here's a roundup of top developments in the biotech space over the last 24 hours:
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for it
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earn
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
Before 10 a.m. ET on Wednesday, 192 companies set new 52-week highs.